Can AI help prevent 10 million cancer deaths per year? Qritive’s Kaveh Taghipour believes so

Diagnosing cancer is like searching for a tiny, disguised needle in a haystack and every second counts. To tackle this immense challenge, Qritive, co-founded by Gen.T Leader of Tomorrow Dr Kaveh Taghipour, is harnessing the power of artificial intelligence for cancer diagnosis.

While there are a few companies in the same space, it is the only company in Singapore, and one of the few worldwide, who have regulatory-approved AI products for cancer diagnosis in pathology labs. 

Says Taghipour, “Even though we are a relatively small company, we have won against our major competitors (who have hundreds of millions of dollars in funding) when our products were compared to competing solutions. This is why we have been referred to as the ‘Porche of histopathology AI companies’ in this field.” 

Read more: Alia Rahman’s breakthrough non-invasive, affordable and accessible treatments for cervical precancer could revolutionise women’s health

To further magnify its impact, Qritive announced a partnership with Swiss healthcare giant Roche in September, allowing them to scale up their AI diagnostic tool and increase the speed and accuracy of cancer diagnosis. Taghipour, who also serves as Qritive’s CTO, explains, “Our partnership with Roche allows us to leverage Roche’s extensive install base, enabling us to deploy our AI solutions on a global scale more efficiently, enhancing their existing digital pathology platform.” 

He adds, “Our AI products are integrated into the familiar Roche [Navify Digital Pathology] interface, allowing hospitals and labs to easily access and implement our solutions without the need for changes to their existing workflows.” 

This technology has the potential to be life-changing for patients, especially considering the devastating global impact of cancer. With 10 million lives lost to cancer each year, the need for early and accurate diagnosis is critical.

According to a statement by Qritive, “These tools have been shown to improve pathology reporting time by up to ten-fold and reduce the risk of misdiagnosis dramatically.” For now, these AI modules can analyse colon, prostate, breast and gastric cancers with accuracy. 

Says Taghipour, “By automating routine tasks, Qritive’s AI helps pathologists reduce stress and improve the accuracy of [pathologists’] reporting, enabling them to focus more on patient care.”

Read more: Professor Dr Teo Soo-Hwang on her illustrious career in cancer research